Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cell and Gene Therapy Market Growth (Status and Outlook) 2022-2028

  • LP 4893323
  • 110 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cell and Gene Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Cell and Gene Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cell and Gene Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cell and Gene Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cell and Gene Therapy market, reaching US$ million by the year 2028. As for the Europe Cell and Gene Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cell and Gene Therapy players cover Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., and Fibrocell Science, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Rare Diseases

Oncology

Hematology

Cardiovascular

Ophthalmology

Neurology

Other Therapeutic Classes

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Pharmaceutical and Biotechnology Companies

Research and Academic Institutions

Contract Research Organizations (CROs)

Hospital

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Amgen Inc.

bluebird bio, Inc.

Dendreon Pharmaceuticals LLC.

Fibrocell Science, Inc.

Human Stem Cells Institute

Kite Pharma, Inc.

Kolon TissueGene, Inc.

Novartis AG

Orchard Therapeutics plc.

Organogenesis Holdings Inc.

Pfizer, Inc.

RENOVA THERAPEUTICS

Shanghai Sunway Biotech Co., Ltd.,

Sibiono GeneTech Co. Ltd.,

Spark Therapeutics, Inc.

Vericel Corporation

ViroMed Co., Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cell and Gene Therapy Market Size 2017-2028

2.1.2 Cell and Gene Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cell and Gene Therapy Segment by Type

2.2.1 Rare Diseases

2.2.2 Oncology

2.2.3 Hematology

2.2.4 Cardiovascular

2.2.5 Ophthalmology

2.2.6 Neurology

2.2.7 Other Therapeutic Classes

2.3 Cell and Gene Therapy Market Size by Type

2.3.1 Cell and Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cell and Gene Therapy Market Size Market Share by Type (2017-2022)

2.4 Cell and Gene Therapy Segment by Application

2.4.1 Pharmaceutical and Biotechnology Companies

2.4.2 Research and Academic Institutions

2.4.3 Contract Research Organizations (CROs)

2.4.4 Hospital

2.4.5 Others

2.5 Cell and Gene Therapy Market Size by Application

2.5.1 Cell and Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cell and Gene Therapy Market Size Market Share by Application (2017-2022)

3 Cell and Gene Therapy Market Size by Player

3.1 Cell and Gene Therapy Market Size Market Share by Players

3.1.1 Global Cell and Gene Therapy Revenue by Players (2020-2022)

3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy by Regions

4.1 Cell and Gene Therapy Market Size by Regions (2017-2022)

4.2 Americas Cell and Gene Therapy Market Size Growth (2017-2022)

4.3 APAC Cell and Gene Therapy Market Size Growth (2017-2022)

4.4 Europe Cell and Gene Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Cell and Gene Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cell and Gene Therapy Market Size by Country (2017-2022)

5.2 Americas Cell and Gene Therapy Market Size by Type (2017-2022)

5.3 Americas Cell and Gene Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cell and Gene Therapy Market Size by Region (2017-2022)

6.2 APAC Cell and Gene Therapy Market Size by Type (2017-2022)

6.3 APAC Cell and Gene Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cell and Gene Therapy by Country (2017-2022)

7.2 Europe Cell and Gene Therapy Market Size by Type (2017-2022)

7.3 Europe Cell and Gene Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cell and Gene Therapy by Region (2017-2022)

8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cell and Gene Therapy Market Forecast

10.1 Global Cell and Gene Therapy Forecast by Regions (2023-2028)

10.1.1 Global Cell and Gene Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Cell and Gene Therapy Forecast

10.1.3 APAC Cell and Gene Therapy Forecast

10.1.4 Europe Cell and Gene Therapy Forecast

10.1.5 Middle East & Africa Cell and Gene Therapy Forecast

10.2 Americas Cell and Gene Therapy Forecast by Country (2023-2028)

10.2.1 United States Cell and Gene Therapy Market Forecast

10.2.2 Canada Cell and Gene Therapy Market Forecast

10.2.3 Mexico Cell and Gene Therapy Market Forecast

10.2.4 Brazil Cell and Gene Therapy Market Forecast

10.3 APAC Cell and Gene Therapy Forecast by Region (2023-2028)

10.3.1 China Cell and Gene Therapy Market Forecast

10.3.2 Japan Cell and Gene Therapy Market Forecast

10.3.3 Korea Cell and Gene Therapy Market Forecast

10.3.4 Southeast Asia Cell and Gene Therapy Market Forecast

10.3.5 India Cell and Gene Therapy Market Forecast

10.3.6 Australia Cell and Gene Therapy Market Forecast

10.4 Europe Cell and Gene Therapy Forecast by Country (2023-2028)

10.4.1 Germany Cell and Gene Therapy Market Forecast

10.4.2 France Cell and Gene Therapy Market Forecast

10.4.3 UK Cell and Gene Therapy Market Forecast

10.4.4 Italy Cell and Gene Therapy Market Forecast

10.4.5 Russia Cell and Gene Therapy Market Forecast

10.5 Middle East & Africa Cell and Gene Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Cell and Gene Therapy Market Forecast

10.5.2 South Africa Cell and Gene Therapy Market Forecast

10.5.3 Israel Cell and Gene Therapy Market Forecast

10.5.4 Turkey Cell and Gene Therapy Market Forecast

10.5.5 GCC Countries Cell and Gene Therapy Market Forecast

10.6 Global Cell and Gene Therapy Forecast by Type (2023-2028)

10.7 Global Cell and Gene Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen Inc.

11.1.1 Amgen Inc. Company Information

11.1.2 Amgen Inc. Cell and Gene Therapy Product Offered

11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Inc. Main Business Overview

11.1.5 Amgen Inc. Latest Developments

11.2 bluebird bio, Inc.

11.2.1 bluebird bio, Inc. Company Information

11.2.2 bluebird bio, Inc. Cell and Gene Therapy Product Offered

11.2.3 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 bluebird bio, Inc. Main Business Overview

11.2.5 bluebird bio, Inc. Latest Developments

11.3 Dendreon Pharmaceuticals LLC.

11.3.1 Dendreon Pharmaceuticals LLC. Company Information

11.3.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered

11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Dendreon Pharmaceuticals LLC. Main Business Overview

11.3.5 Dendreon Pharmaceuticals LLC. Latest Developments

11.4 Fibrocell Science, Inc.

11.4.1 Fibrocell Science, Inc. Company Information

11.4.2 Fibrocell Science, Inc. Cell and Gene Therapy Product Offered

11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Fibrocell Science, Inc. Main Business Overview

11.4.5 Fibrocell Science, Inc. Latest Developments

11.5 Human Stem Cells Institute

11.5.1 Human Stem Cells Institute Company Information

11.5.2 Human Stem Cells Institute Cell and Gene Therapy Product Offered

11.5.3 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Human Stem Cells Institute Main Business Overview

11.5.5 Human Stem Cells Institute Latest Developments

11.6 Kite Pharma, Inc.

11.6.1 Kite Pharma, Inc. Company Information

11.6.2 Kite Pharma, Inc. Cell and Gene Therapy Product Offered

11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Kite Pharma, Inc. Main Business Overview

11.6.5 Kite Pharma, Inc. Latest Developments

11.7 Kolon TissueGene, Inc.

11.7.1 Kolon TissueGene, Inc. Company Information

11.7.2 Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered

11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Kolon TissueGene, Inc. Main Business Overview

11.7.5 Kolon TissueGene, Inc. Latest Developments

11.8 Novartis AG

11.8.1 Novartis AG Company Information

11.8.2 Novartis AG Cell and Gene Therapy Product Offered

11.8.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Novartis AG Main Business Overview

11.8.5 Novartis AG Latest Developments

11.9 Orchard Therapeutics plc.

11.9.1 Orchard Therapeutics plc. Company Information

11.9.2 Orchard Therapeutics plc. Cell and Gene Therapy Product Offered

11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Orchard Therapeutics plc. Main Business Overview

11.9.5 Orchard Therapeutics plc. Latest Developments

11.10 Organogenesis Holdings Inc.

11.10.1 Organogenesis Holdings Inc. Company Information

11.10.2 Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered

11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Organogenesis Holdings Inc. Main Business Overview

11.10.5 Organogenesis Holdings Inc. Latest Developments

11.11 Pfizer, Inc.

11.11.1 Pfizer, Inc. Company Information

11.11.2 Pfizer, Inc. Cell and Gene Therapy Product Offered

11.11.3 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Pfizer, Inc. Main Business Overview

11.11.5 Pfizer, Inc. Latest Developments

11.12 RENOVA THERAPEUTICS

11.12.1 RENOVA THERAPEUTICS Company Information

11.12.2 RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered

11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 RENOVA THERAPEUTICS Main Business Overview

11.12.5 RENOVA THERAPEUTICS Latest Developments

11.13 Shanghai Sunway Biotech Co., Ltd.,

11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Information

11.13.2 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered

11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Shanghai Sunway Biotech Co., Ltd., Main Business Overview

11.13.5 Shanghai Sunway Biotech Co., Ltd., Latest Developments

11.14 Sibiono GeneTech Co. Ltd.,

11.14.1 Sibiono GeneTech Co. Ltd., Company Information

11.14.2 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered

11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Sibiono GeneTech Co. Ltd., Main Business Overview

11.14.5 Sibiono GeneTech Co. Ltd., Latest Developments

11.15 Spark Therapeutics, Inc.

11.15.1 Spark Therapeutics, Inc. Company Information

11.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered

11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Spark Therapeutics, Inc. Main Business Overview

11.15.5 Spark Therapeutics, Inc. Latest Developments

11.16 Vericel Corporation

11.16.1 Vericel Corporation Company Information

11.16.2 Vericel Corporation Cell and Gene Therapy Product Offered

11.16.3 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Vericel Corporation Main Business Overview

11.16.5 Vericel Corporation Latest Developments

11.17 ViroMed Co., Ltd.

11.17.1 ViroMed Co., Ltd. Company Information

11.17.2 ViroMed Co., Ltd. Cell and Gene Therapy Product Offered

11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 ViroMed Co., Ltd. Main Business Overview

11.17.5 ViroMed Co., Ltd. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Cell and Gene Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Rare Diseases

Table 3. Major Players of Oncology

Table 4. Major Players of Hematology

Table 5. Major Players of Cardiovascular

Table 6. Major Players of Ophthalmology

Table 7. Major Players of Neurology

Table 8. Major Players of Other Therapeutic Classes

Table 9. Cell and Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Cell and Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Cell and Gene Therapy Market Size Market Share by Type (2017-2022)

Table 12. Cell and Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Cell and Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Cell and Gene Therapy Market Size Market Share by Application (2017-2022)

Table 15. Global Cell and Gene Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Cell and Gene Therapy Revenue Market Share by Player (2020-2022)

Table 17. Cell and Gene Therapy Key Players Head office and Products Offered

Table 18. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Cell and Gene Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Cell and Gene Therapy Market Size Market Share by Regions (2017-2022)

Table 23. Americas Cell and Gene Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Cell and Gene Therapy Market Size Market Share by Country (2017-2022)

Table 25. Americas Cell and Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Cell and Gene Therapy Market Size Market Share by Type (2017-2022)

Table 27. Americas Cell and Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Cell and Gene Therapy Market Size Market Share by Application (2017-2022)

Table 29. APAC Cell and Gene Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Cell and Gene Therapy Market Size Market Share by Region (2017-2022)

Table 31. APAC Cell and Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Cell and Gene Therapy Market Size Market Share by Type (2017-2022)

Table 33. APAC Cell and Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Cell and Gene Therapy Market Size Market Share by Application (2017-2022)

Table 35. Europe Cell and Gene Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Cell and Gene Therapy Market Size Market Share by Country (2017-2022)

Table 37. Europe Cell and Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Cell and Gene Therapy Market Size Market Share by Type (2017-2022)

Table 39. Europe Cell and Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Cell and Gene Therapy Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Cell and Gene Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Cell and Gene Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Cell and Gene Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy

Table 48. Key Market Challenges & Risks of Cell and Gene Therapy

Table 49. Key Industry Trends of Cell and Gene Therapy

Table 50. Global Cell and Gene Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Cell and Gene Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Cell and Gene Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Cell and Gene Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 56. Amgen Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 57. Amgen Inc. Cell and Gene Therapy Product Offered

Table 58. Amgen Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Amgen Inc. Main Business

Table 60. Amgen Inc. Latest Developments

Table 61. bluebird bio, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 62. bluebird bio, Inc. Cell and Gene Therapy Product Offered

Table 63. bluebird bio, Inc. Main Business

Table 64. bluebird bio, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. bluebird bio, Inc. Latest Developments

Table 66. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 67. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered

Table 68. Dendreon Pharmaceuticals LLC. Main Business

Table 69. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Dendreon Pharmaceuticals LLC. Latest Developments

Table 71. Fibrocell Science, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 72. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered

Table 73. Fibrocell Science, Inc. Main Business

Table 74. Fibrocell Science, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Fibrocell Science, Inc. Latest Developments

Table 76. Human Stem Cells Institute Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 77. Human Stem Cells Institute Cell and Gene Therapy Product Offered

Table 78. Human Stem Cells Institute Main Business

Table 79. Human Stem Cells Institute Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Human Stem Cells Institute Latest Developments

Table 81. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 82. Kite Pharma, Inc. Cell and Gene Therapy Product Offered

Table 83. Kite Pharma, Inc. Main Business

Table 84. Kite Pharma, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Kite Pharma, Inc. Latest Developments

Table 86. Kolon TissueGene, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 87. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered

Table 88. Kolon TissueGene, Inc. Main Business

Table 89. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Kolon TissueGene, Inc. Latest Developments

Table 91. Novartis AG Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 92. Novartis AG Cell and Gene Therapy Product Offered

Table 93. Novartis AG Main Business

Table 94. Novartis AG Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Novartis AG Latest Developments

Table 96. Orchard Therapeutics plc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 97. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered

Table 98. Orchard Therapeutics plc. Main Business

Table 99. Orchard Therapeutics plc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Orchard Therapeutics plc. Latest Developments

Table 101. Organogenesis Holdings Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 102. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered

Table 103. Organogenesis Holdings Inc. Main Business

Table 104. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Organogenesis Holdings Inc. Latest Developments

Table 106. Pfizer, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 107. Pfizer, Inc. Cell and Gene Therapy Product Offered

Table 108. Pfizer, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 109. Pfizer, Inc. Main Business

Table 110. Pfizer, Inc. Latest Developments

Table 111. RENOVA THERAPEUTICS Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 112. RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered

Table 113. RENOVA THERAPEUTICS Main Business

Table 114. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. RENOVA THERAPEUTICS Latest Developments

Table 116. Shanghai Sunway Biotech Co., Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 117. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered

Table 118. Shanghai Sunway Biotech Co., Ltd., Main Business

Table 119. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Shanghai Sunway Biotech Co., Ltd., Latest Developments

Table 121. Sibiono GeneTech Co. Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 122. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered

Table 123. Sibiono GeneTech Co. Ltd., Main Business

Table 124. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Sibiono GeneTech Co. Ltd., Latest Developments

Table 126. Spark Therapeutics, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 127. Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered

Table 128. Spark Therapeutics, Inc. Main Business

Table 129. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Spark Therapeutics, Inc. Latest Developments

Table 131. Vericel Corporation Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 132. Vericel Corporation Cell and Gene Therapy Product Offered

Table 133. Vericel Corporation Main Business

Table 134. Vericel Corporation Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Vericel Corporation Latest Developments

Table 136. ViroMed Co., Ltd. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors

Table 137. ViroMed Co., Ltd. Cell and Gene Therapy Product Offered

Table 138. ViroMed Co., Ltd. Main Business

Table 139. ViroMed Co., Ltd. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. ViroMed Co., Ltd. Latest Developments

List of Figures

Figure 1. Cell and Gene Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cell and Gene Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cell and Gene Therapy Market Size Market Share by Type in 2021

Figure 7. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies

Figure 8. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2017-2022) & ($ Millions)

Figure 9. Cell and Gene Therapy in Research and Academic Institutions

Figure 10. Global Cell and Gene Therapy Market: Research and Academic Institutions (2017-2022) & ($ Millions)

Figure 11. Cell and Gene Therapy in Contract Research Organizations (CROs)

Figure 12. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2017-2022) & ($ Millions)

Figure 13. Cell and Gene Therapy in Hospital

Figure 14. Global Cell and Gene Therapy Market: Hospital (2017-2022) & ($ Millions)

Figure 15. Cell and Gene Therapy in Others

Figure 16. Global Cell and Gene Therapy Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Cell and Gene Therapy Market Size Market Share by Application in 2021

Figure 18. Global Cell and Gene Therapy Revenue Market Share by Player in 2021

Figure 19. Global Cell and Gene Therapy Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Cell and Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 21. APAC Cell and Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 22. Europe Cell and Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Cell and Gene Therapy Market Size 2017-2022 ($ Millions)

Figure 24. Americas Cell and Gene Therapy Value Market Share by Country in 2021

Figure 25. Americas Cell and Gene Therapy Consumption Market Share by Type in 2021

Figure 26. Americas Cell and Gene Therapy Market Size Market Share by Application in 2021

Figure 27. United States Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Cell and Gene Therapy Market Size Market Share by Region in 2021

Figure 32. APAC Cell and Gene Therapy Market Size Market Share by Application in 2021

Figure 33. China Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Cell and Gene Therapy Market Size Market Share by Country in 2021

Figure 40. Europe Cell and Gene Therapy Market Size Market Share by Type in 2021

Figure 41. Europe Cell and Gene Therapy Market Size Market Share by Application in 2021

Figure 42. Germany Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application in 2021

Figure 50. Egypt Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Cell and Gene Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 56. APAC Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 57. Europe Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 59. United States Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Canada Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 63. China Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Japan Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 65. Korea Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 67. India Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Australia Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Germany Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 70. France Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 71. UK Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Italy Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Russia Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Spain Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 77. Israel Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Cell and Gene Therapy Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450